Explore

Trendline Trendline
Viking and Structure Therapeutics Become Key Targets in Metabolic Health Sector

Viking and Structure Therapeutics Become Key Targets in Metabolic Health Sector

Viking and Structure Therapeutics Become Key Targets in Metabolic Health Sector
Trendline Trendline
SV Health Investors Acquires EpiVax, Expanding Pharma Services Portfolio

SV Health Investors Acquires EpiVax, Expanding Pharma Services Portfolio

SV Health Investors Acquires EpiVax, Expanding Pharma Services Portfolio
Trendline Trendline
SV Health Investors Acquires EpiVax to Enhance Immunogenicity Risk Assessment Services

SV Health Investors Acquires EpiVax to Enhance Immunogenicity Risk Assessment Services

SV Health Investors Acquires EpiVax to Enhance Immunogenicity Risk Assessment Services
Trendline Trendline
Pharmaceutical Companies Engage in Record M Activity Amid Challenging Environment

Pharmaceutical Companies Engage in Record M Activity Amid Challenging Environment

Pharmaceutical Companies Engage in Record M Activity Amid Challenging Environment
Trendline Trendline
IQVIA Reports Mixed Q4 Earnings with Revenue Growth but Stock Decline

IQVIA Reports Mixed Q4 Earnings with Revenue Growth but Stock Decline

IQVIA Reports Mixed Q4 Earnings with Revenue Growth but Stock Decline
Trendline Trendline
Pharma M Activity Surges with Record Highs Anticipated in 2026

Pharma M Activity Surges with Record Highs Anticipated in 2026

Pharma M Activity Surges with Record Highs Anticipated in 2026
AP News AP News
Providence's Duncan Powell pleads not guilty to charges resulting from altercation with woman

Providence's Duncan Powell pleads not guilty to charges resulting from altercation with woman

Providence basketball player Duncan Powell for the second time this week has pleaded not guilty to domestic assault and disorderly conduct charges stemming from a weekend altercation with a woman that started in Providence and continued in the suburb of Cranston
Trendline Trendline
Thermo Fisher Scientific Introduces Platform to Expedite Biologics Development

Thermo Fisher Scientific Introduces Platform to Expedite Biologics Development

Thermo Fisher Scientific Introduces Platform to Expedite Biologics Development
Trendline Trendline
Thermo Fisher Scientific Launches Platform to Accelerate Biologics Development

Thermo Fisher Scientific Launches Platform to Accelerate Biologics Development

Thermo Fisher Scientific Launches Platform to Accelerate Biologics Development
Trendline Trendline
Alpha Cognition Secures U.S. Patent for ALPHA-1062, Targeting Traumatic Brain Injury

Alpha Cognition Secures U.S. Patent for ALPHA-1062, Targeting Traumatic Brain Injury

Alpha Cognition Secures U.S. Patent for ALPHA-1062, Targeting Traumatic Brain Injury
Trendline Trendline
TriNetX and Regeneron Collaborate to Enhance Drug Discovery with Access to 300 Million Patient Health Records

TriNetX and Regeneron Collaborate to Enhance Drug Discovery with Access to 300 Million Patient Health Records

TriNetX and Regeneron Collaborate to Enhance Drug Discovery with Access to 300 Million Patient Health Records
Trendline Trendline
PharmaEssentia Announces New Manufacturing Facility in Puerto Rico, Enhancing U.S.-Taiwan Biopharmaceutical Collaboration

PharmaEssentia Announces New Manufacturing Facility in Puerto Rico, Enhancing U.S.-Taiwan Biopharmaceutical Collaboration

PharmaEssentia Announces New Manufacturing Facility in Puerto Rico, Enhancing U.S.-Taiwan Biopharmaceutical Collaboration